Insiders · Profile

FREEMAN KEVIN D

Director at GALECTIN THERAPEUTICS. Filing since 28 May 2013. CIK 0001522478

Company
Date
Role
Action
Shares
Amount
Of holding
23 Dec 2025
Director
Bought on a plan
5,500
$19.51K
11.1%
17 Jul 2025
Director
Bought
5,000
$14.50K
11.2%
24 Dec 2024
Director
Bought
10,000
$8.13K
28.8%
17 Oct 2024
Director
Bought
1,300
$3.43K
3.9%
16 Oct 2024
Director
Bought
5,000
$13.50K
6.7%
16 Oct 2024
Director
Bought
5,000
$13.50K
17.6%
20 Jun 2024
Director
Bought
2,500
$5.95K
9.6%
22 Apr 2024
Director
Bought
2,500
$7.45K
10.7%
28 Oct 2022
Director
Bought
10,000
$14.10K
15.4%
19 May 2022
Director
Bought
5,000
$6.65K
8.3%
18 Apr 2022
Director
Bought
5,000
$8.55K
9.1%
19 Jan 2022
Director
Bought
5,000
$9.81K
11.1%
6 Dec 2021
Director
Bought
10,000
$23.10K
25.0%
29 Oct 2021
Director
Bought
2,000
$6.34K
5.3%
21 Oct 2021
Director
Bought
2,000
$6.38K
5.6%
19 Oct 2021
Director
Bought
3,000
$10.11K
9.1%
23 Sep 2021
Director
Bought
3,000
$11.63K
10.0%
5 Apr 2021
Director
Bought
5,000
$10.20K
20.0%
4 Sep 2020
Director
Bought
5,000
$12.85K
25.0%
19 Mar 2020
Director
Bought
6,000
$9.84K
42.9%
15 Nov 2019
Director
Bought
3,000
$10.08K
27.3%
6 Sep 2019
Director
Bought
1,290
$4.79K
13.3%
31 May 2019
Director
Bought
7,710
$33.00K
386%
31 May 2019
Director
Bought
1,426
$6.10K
6.5%
5 Apr 2019
Director
Bought
500
$2.37K
33.3%
8 Feb 2019
Director
Bought
1,500
$6.43K
opened
1 Feb 2018
Director
Bought
4,000
$16.38K
33.3%
7 Dec 2017
Director
Bought
8,000
$13.00K
opened
7 Dec 2017
Director
Bought
400
$657.32
1.4%
1 Jun 2015
Director
Bought
2,083
$5.62K
opened
15 Aug 2014
Director
Bought
1,000
$4.70K
34.3%
18 Nov 2013
Director
Bought
1,000
$6.08K
52.2%
28 May 2013
Director
Bought
1,000
$4.21K
18.2%
33 decisions on file.